In the heart of Nairobi, a team of dedicated researchers is poised to revolutionize maternal healthcare, potentially reshaping the future of pregnancy outcomes for women. Led by Dr. Moses Obimbo Madadi, a Clinician-Scientist and Associate Professor at the University of Nairobi, this groundbreaking project is shedding light on the intricate relationship between vaginal infections, reproductive health, and neonatal mortality rates in Africa, where 27 deaths per 1,000 live births remain a stark reality. What has been established so far is that
In some resource-limited settings in Nigeria, reusable pads are being used as a sustainable solution to period poverty that can help girls stay in school and manage their menstruation with dignity. But the scale of this initiative may not be big enough to have statistically significant impact(s) on national metrics. Halima Akande is among thousands of girls who miss school several days every month—once her menstruation comes. She fears any stain showing on her dress, cannot focus in class or
A recent study showed drug sellers were the only source of information about misoprostol for three-quarters of the 400 women aged 18–49 who self-managed an abortion using misoprostol. The study found that most women who participated in the study did not receive adequate or accurate information about how to administer misoprostol, how much to use, or what to expect during the abortion process. For example, only 67% of participants were told to anticipate bleeding and 35% were told to expect cramping,
According to the World Health Organisation (WHO), about 75% of all abortions in Africa are unsafe. It added that across the world, women in Africa have the highest risk of dying from unsafe abortion. While the WHO recently raised alarm regarding unsafe abortion, the situation is most severe in Africa where abortion is largely unsafe and the risk of dying is highest but this does not mean that it is not a global crisis. According to the WHO, 45% of
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has announced that it is strongly encouraged by new study results showing that the antiretroviral medicine cabotegravir, which is administered by injection every two months, prevents HIV among women. The study shows that the long-acting injections among women in sub-Saharan Africa were 89% more efficient in preventing HIV compared to daily tablets of pre-exposure prophylaxis (PrEP). “These results are hugely significant. UNAIDS has long been calling for additional, acceptable and effective HIV prevention options
Using the hashtag, #PCOSWithMedplus, Nigeria’s leading health and beauty retail pharmaceutical chain, Medplus Pharmacy reached out to audiences to share their stories with PCOS and its relevant symptoms, from irregular periods, difficulty getting pregnant, weight gain, to excessive hair growth. Mrs. Joke Bakare, Medplus Founder and CEO, commented, “PCOS is a major condition that impacts several aspects of life for women, but yet, it tends to be under-recognized by women as they have no idea what their symptoms mean, and end